Effects of a single transdermal nicotine dose on cognitive performance in adults with Down syndrome.

Subjects with Down syndrome exhibit various types of cognitive impairment. Neuropathological and neurochemical studies revealed similarities between Down syndrome and Alzheimer's disease, cholinergic deficits being the most consistent findings. To explore the potential for cognitive enhancement utilizing nicotinic stimulation, 8 patients with Down syndrome (aged 18.5-31 years) received placebo and a single dose of transdermal nicotine (5 mg patch) over 2h in a single-blind, within-subjects repeated measures design. Auditory event-related potentials (ERPs) and neuropsychological tests, comprising digit symbol performance subtest from WAIS-R and the Frankfurt Attention Inventory (FAIR) were performed. Effects of nicotine administration in Down syndrome individuals were a decrease of ERP-P3 latency in 7 of 8 subjects (electrode position Cz: 386.9+/-24.0 ms vs. 363.1+/-26.9.2 ms, placebo vs. nicotine, respectively; P = 0.058) and an increase of ERP-P3 amplitude in 6 of 8 subjects (electrode position Cz: 17.4+/-5.5 vs. 18.0+/-4.5 microV, placebo vs. nicotine respectively; P = 0.725). Neuropsychological tests exhibited improvements in digit symbol performance subtest in 4 of 8 subjects and 7 of 8 subjects in the Frankfurt Attention Inventory. These results suggest that stimulating central nicotinic receptors might have an acute cognitive benefit in young adult Down syndrome subjects.

The circadian rhythm of selected parameters of heart rate variability.

At present, two main circadian oscillators are known, responsible for the rhythm of body temperature (BT) and body activity. Their independence has been demonstrated by the dissociation of these two rhythms in people during long-term isolation. In order to ascertain the circadian rhythm (CR) of heart rate variability (HRV), the ECG was recorded in 24 healthy awake men every two hours in the sitting position, from Friday 5 p.m. to Monday 6 a.m., who were maintained on a standard regime. One hundred consecutive RR intervals in every ECG were measured and from these 11 selected indicators of HRV were computed. Chronograms from the means of BT, respiratory rate, and electrical skin resistance showed pronounced CR with acrophases at 6 to 8 p.m. "Frequency" parameters of HRV, especially the frequency of reversal points, behaved similarly. CR in the remaining 7 "amplitude" parameters was also detected in individual persons, but their acrophases were different, and averaged chronograms mostly exhibited a flat course. The study has shown that there are at least two circadian components of HRV: the first phase has the CR synchronized with BT and is interindividually more homogeneous; the second phase is synchronized with body activity rhythm and is interindividually heterogeneous. On this basis, three equal subgroups of subjects arose, tentatively called afternoon, night, and forenoon types, respectively, in accordance with information about their preference for working and sleeping.